BridgeMD
IMPROCAS - Improved Prediction of Ovarian Cancer Surgery
EU CTIS ID: 2023-503398-39-00
What this study is testing
The aim of this project is to investigate nuclear magnetic resonance (NMR)-derived metabolomics from blood samples, functional and metabolic MRI techniques and their ability to improve ovarian cancer diagnostics. Based on the above, a model able to identify ovarian cancer and improve the accuracy of correct diagnosis and disease severity will be proposed.
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- - Suspected epithelial ovarian cancer (and referred to dept. of Gynaecology and Obstetrics, AUH)
- - Understanding Danish
- - Age 18 – 85 years
You likely can't join if
- Contraindications for MRI with contrast: - eGFR less than 30 ml/min/1.73m2 - Severe unstable asthma - Pacemaker, implantable cardiac defibrillator, neurostimulator or cochlear implant - Metal foreign bodies such as fragments and irremovable piercings - Unsafe medical implants (safety of heart valves, hips and the like must be confirmed) - Claustrophobia - Largest circumference including arms > 160 cm
- Substantial cognitive disability that would influence the patients’ ability to either give truly informed consent or listen to / comply with safety-related instructions.
- Severe renovascular disease
- Any other malign disease or recidiv of a former malign disease present within the last 3-5 years (except benign basal basocelluar carcinoma (BBC))
- Pregnancy
- Allergy to pyruvate
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.